Chitosan-Coated PLGA Nanoparticles Encapsulating Triamcinolone Acetonide as a Potential Candidate for Sustained Ocular Drug Delivery

The current treatment for the acquired retinal vasculopathies involves lifelong repeated intravitreal injections of either anti-vascular endothelial growth factor (VEGF) therapy or modulation of inflammation with steroids. Consequently, any treatment modification that decreases this treatment burden...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandamudi, Madhuri, McLoughlin, Peter, Behl, Gautam, Rani, Sweta, Coffey, Lee, Chauhan, Anuj, Kent, David, Fitzhenry, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541202/
https://www.ncbi.nlm.nih.gov/pubmed/34683883
http://dx.doi.org/10.3390/pharmaceutics13101590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541202/
https://www.ncbi.nlm.nih.gov/pubmed/34683883
http://dx.doi.org/10.3390/pharmaceutics13101590

Ejemplares similares